Global Ceramics Biomaterials Market Research Report
- Report Code: CE 1000
- Publish Date: Upcoming
The Global Ceramics Biomaterials Market is driven by unique properties such as biocompatibility, high resistance to corrosion and compression, low electrical and thermal conductivities, making them highly suitable for implants, which makes them suitable for usage in various medical applications such as orthopedic, cardiovascular, wound healing, and dentistry, and procedures. The market value of the market was $13.76 billion in 2013 and estimated to be $26.52 billion by 2018, at a CAGR of 14.10%. The ceramics biomaterials has market share of 25% of overall biomaterials market.
The report “Ceramics Biomaterials Market Forecast, 2008-2018”, analyzes the market of ceramics biomaterials in terms of products classified as aluminium oxide, zirconia, calcium phosphate, calcium sulfate, carbon, and glass. Ceramics are used in dental parts, coatings, bone fillings, endoscopy, ontological implants, medical tools and equipment, drug delivery and cardiovascular applications, boosting the growth of ceramics biomaterials market. Ceramics biomaterials are also used in maxillofacial surgery as dental material. All of these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. In 2012, the cardiovascular application accounted for 34.5%, followed by orthopedics, which accounted for 34.2% of the total market. Plastic surgery and wound healing application areas are estimated to grow at CAGR of 18.50% and 17.8%, respectively.
The global Ceramics biomaterials market was dominated by the U.S. in 2012, followed by Europe, Asia, and Rest of the World (RoW). The Asian ceramics biomaterial market is estimated to grow at a CAGR of 21.50% due to a large population base with disorders, necessitating the use of biomaterial-based medical products.
Increased investments, funding and grants by the institutions of the government, incessant rise in the number of collaborations, conferences and research-related activities, technological advancements, increasing applications of biomaterials, and aging population are factors propelling the growth of the biomaterials market. A large amount of research has also been taking place in China, significantly driving the growth of the biomaterial market in the country, as per the Chinese Society for Biomaterials. The Ninth World Biomaterial Congress, which was held in China on June 2012, discussed the usage of biomaterials in tissue engineering, regenerative medicine, and surface characterization of biomaterials.
The report also provides an extensive competitive landscaping of companies operating in ceramics biomaterials market. Major players in ceramics biomaterials market covered in the report are DENTSPLY International, Inc. (U.S.), Wright Medical Group, Inc. (U.S.), DePuy Orthopaedics, Inc. (U.S.), Invibio Ltd. (U.K.), Osteotech, Inc. (U.S.), Biomet, Inc. (U.S.), Berkeley Advanced Biomaterials, Inc. (U.S.), Depuy Orthopaedics, Inc. (U.S.), Orthovita, Inc. (U.S.), and others. The key raw material supplier companies are Carpenter Technology Corporation (U.S.), Materion Corporation (U.S.), Ulbrich Stainless Steel & Special Metals, Inc. (U.S.), Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), (Germany), Ceradyne, Inc. (U.S.), Kyocera Corporation (Japan), Bayer (Germany), Purac Biomaterials (Netherlands), DSM Biomedical, Inc. (U.S.), Evonik Industries (Germany), Cam Bioceramics (Netherlands), Ticona GmbH (Germany) and Landec Corporation (U.S.). The details of segment and country specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals and product recalls of the major companies is covered in the report.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country specific prevalence of knee, hand, hip, spine osteoarthritis (OA) and rheumatoid arthritis (RA), heart attack, stroke and ischemia
- Country specific incidence of knee, hand, hip, spine (OA) and (RA), heart attack, stroke and ischemia
- Country specific patient pool of Knee, Hand, Hip, Spine OA and RA, heart attack, stroke, ischemia
- Mortality rate of heart failure, stroke and ischemia
- Disease progression (pattern analysis)
Procedure Volume Data
- Bilateral and Unilateral hip and knee procedures performed annually in each country tracked till sub-segment level
- Number of foot and ankle, wrist, shoulder, elbow, digit and disc replacement procedures performed in each country
- Number of heart surgeries performed in each country
- Number of maxillofacial and jaw surgeries performed in each country
Surgeon’s/Physician’s Forum
- Fast turn-around analysis of surgeons response to market events and trends
- Pattern analysis of usage of ceramics biomaterials by physicians
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis ceramics biomaterials in major countries
- Hip and knee, heart surgeries, maxillofacial and jaw procedural investment in major countries
Competitive Intelligence
- The company share analysis of ceramics biomaterials market top players in the region
- The crucial developments and strategies of companies inculcating in their portfolio of ceramics biomaterials market
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals, Orthopedic clinics, Dental clinics, cardiac centers, and skin clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Types
4.1 Aluminium Hydroxide OR Aluminum Trihydrate (ATH)
4.2 Zirconium Dioxide OR Zirconia
4.3 Calcium Phosphate
4.4 Calcium Sulphate
4.5 Carbon
4.6 Glass
5 By Materials
5.1 Aluminium Oxide
5.2 Zirconia
5.3 Calcium Phosphate
5.4 Calcium Sulfate
5.5 Carbon
5.6 Glass
6 By Geographies
6.1 North America
6.2 Europe
6.3 Asia-Pacific
6.4 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Aluminium Oxide Aluminium Oxide and Zirconia, Calcium Phosphate, |
Upcoming |
|
|
Zirconia Zirconia and Aluminium Oxide, Calcium Phosphate, |
Upcoming |
|
|
Calcium Phosphate Calcium Phosphate and Aluminium Oxide, Zirconia, |
Upcoming |
|
|
Calcium Sulfate Calcium Sulfate and Aluminium Oxide, Zirconia, |
Upcoming |
|
|
Carbon Carbon and Aluminium Oxide, Zirconia, |
Upcoming |
|
|
Glass Glass and Aluminium Oxide, Zirconia, |
Upcoming |
|
|
North American Ceramics Biomaterials The North American ceramic biomaterial market was valued at $4.69 million in 2013 and is estimated to reach $8.37 million by 2018, at a CAGR of 12.3% during the forecast period. The market is segmented by products classified as aluminium oxides, zirconia, calcium phosphate, calcium sulfate, carbon, and glass The report also provides an extensive competitive landscaping of companies operating in this market. Major players are Dentsply International, Inc. (U.S.), Wright Medical Group, Inc. (U.S.), DePuy Orthopaedics, Inc. (U.S.), Invibio Ltd. (U.K.), Osteotech, Inc. (U.S.), Biomet, Inc. (U.S.), Berkeley Advanced Biomaterials, Inc. (U.S.), Depuy Orthopaedics, Inc. (U.S.), Orthovita, Inc. (U.S.), and others. |
Upcoming |
|
|
European Ceramics Biomaterials The European ceramic biomaterial market was valued at $3.45 million in 2013 and is estimated to reach $5.58 million by 2018, at a CAGR of 10.1% during the forecast period of 2013 to 2018. The market is segmented by products classified as aluminium oxides, zirconia, calcium phosphate, calcium sulfate, carbon, and glass The report also provides an extensive competitive landscaping of companies operating in this market. Major players are Dentsply International, Inc. (U.S.), Wright Medical Group, Inc. (U.S.), DePuy Orthopaedics, Inc. (U.S.), Invibio Ltd. (U.K.), Osteotech, Inc. (U.S.), Biomet, Inc. (U.S.), Berkeley Advanced Biomaterials, Inc. (U.S.), Depuy Orthopaedics, Inc. (U.S.), Orthovita, Inc. (U.S.), and others. |
Upcoming |
|
|
Asian Ceramics Biomaterials The Asian ceramic biomaterial market is segmented by products classified as aluminium oxides, zirconia, calcium phosphate, calcium sulfate, carbon, and glass. The market was valued at $2.3 million in 2013 and is estimated to be $5.83 million by 2018, at a CAGR of 20.4% during the forecast period. The ceramic biomaterial market constitutes 25% of the overall biomaterial market.The report also provides an extensive competitive landscaping of companies operating in this market. Major players are Dentsply International, Inc. (U.S.), Wright Medical Group, Inc. (U.S.), DePuy Orthopaedics, Inc. (U.S.), Invibio Ltd. (U.K.), Osteotech, Inc. (U.S.), Biomet, Inc. (U.S.), Berkeley Advanced Biomaterials, Inc. (U.S.), Depuy Orthopaedics, Inc. (U.S.), Orthovita, Inc. (U.S.), and others. |
Upcoming |
